Page 136 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 136
asthma: is the doctor or the patient to 17. Banac S, Rožmanić V, Manestar K,
blame? The DIMCA project. Thorax. et al. Rising trends in the prevalence
severe asthma forum 1: severe asthma - basic and clinical views 2000 Jul;55(7):562-5. of asthma and allergic diseases among
9. Kavanagh J, Jackson DJ, Kent BD. school children in the north-west coast-
Over- and under-diagnosis in asthma. al part of Croatia. J Asthma. 2013 Oct;
Breathe. 2019 Mar;15(1):e20-e27. 50(8):810-4.
10. Chung KF, Wenzel SE, Brozek JL, et
al. International ERS/ATS guidelines 18. Denlinger LC, Phillips BR, Ramrat-
on definition, evaluation and treatment nam S, et al. National Heart Lung and
of severe asthma. Eur Respir J. 2014 Blood Institute’s Severe Asthma Re-
Feb;43(2):343-73. search Program-3 Investigators. Inflam-
11. Reddel HK, Bateman ED, Becker A, et matory and comorbid features of pa-
al. A summary of the new GINA strat- tients with severe asthma and frequent
egy: a roadmap to asthma control. Eur exacerbations. Am J Respir Crit Care
Respir J. 2015 Sep;46(3):622-39. Med. 2017 Feb 1;195(3):302-13.
12. Pavord I, Bahmer T, Braido F, et al. Se-
vere T2-high asthma in the biologicals 19. Reddel HK, Taylor DR, Bateman ED,
era: European experts’ opinion. Eur et al. An official American Thoracic
Respir Rev. 2019 Jul 8;28(152):190054. Society/European Respiratory Socie-
doi: 10.1183/16000617.0054-2019. ty statement: asthma control and exac-
13. Eger KAB, Amelink M, Hekking erbations: standardizing endpoints for
PP, et al. Overuse of oral corticos- clinical asthma trials and clinical prac-
teroids in asthma – modifiable fac- tice. Am J Respir Crit Care Med. 2009
tors and potential role of biologics. Jul 1;180(1):59-99.
Eur Respir J. 2019;54:OA5334; doi:
10.1183/13993003.congress-2019. 20. Loymans RJ, Sterk PJ. Exacerba-
OA5334. tor-prone asthma: a separate bioclini-
14. Suehs CM, Menzies-Gow A, Price cal phenotype? Am J Respir Crit Care
D, et al. Expert Consensus on the Ta- Med. 2017 Feb 1;195(3):275-7.
pering of Oral Corticosteroids for the
Treatment of Asthma. A Delphi Study. 21. Moore WC, Meyers DA, Wenzel SE,
Am J Respir Crit Care Med. 2021 Apr et al. Identification of asthma pheno-
1;203(7):871-81. types using cluster analysis in the Se-
15. To T, Stanojevic S, Moores G, et al. vere Asthma Research Program. Am
Global asthma prevalence in adults: J Respir Crit Care Med. 2010 Feb
finding from the cross-sectional world 15;181(4):315-23.
health survey. BMC Public Heath. 2012
Mar 19;12:204. doi: 10.1186/1471- 22. Federico MJ, Denlinger LC, Corren J,
2458-12-204. et al. Exacerbation-Prone Asthma: A
16. Stipić-Marković A, Pevec B, Radu- Biological Phenotype or a Social Con-
lović-Pevec M, et al. Prevalence of struct. J Allergy Clinical Immunol
symptoms of asthma, allergic rhini- Pract. 2021 Jul; 9(7):2627-34.
tis, conjunctivitis and atopic eczema:
ISAAC(International Study of Asthma 23. Ramsahai JM, Wark PAB. Appropri-
and Allergies in Childhood. in a pop- ate use of oral corticosteroids for se-
ulation of schoolchildren in Zagreb. vere asthma. Med J Aust. 2018 Jul
Acta Med Croatica. 2003;57(4):281-5. 16;209(S2):S18-S21.
24. Woodruff PG, Modrek B, Choy DF, et
al. T-helper type 2-driven inflammation
defines major subphenotypes of asthma.
Am J Respir Crit Care Med. 2009 Sep
1;80(5):388-95.
blame? The DIMCA project. Thorax. et al. Rising trends in the prevalence
severe asthma forum 1: severe asthma - basic and clinical views 2000 Jul;55(7):562-5. of asthma and allergic diseases among
9. Kavanagh J, Jackson DJ, Kent BD. school children in the north-west coast-
Over- and under-diagnosis in asthma. al part of Croatia. J Asthma. 2013 Oct;
Breathe. 2019 Mar;15(1):e20-e27. 50(8):810-4.
10. Chung KF, Wenzel SE, Brozek JL, et
al. International ERS/ATS guidelines 18. Denlinger LC, Phillips BR, Ramrat-
on definition, evaluation and treatment nam S, et al. National Heart Lung and
of severe asthma. Eur Respir J. 2014 Blood Institute’s Severe Asthma Re-
Feb;43(2):343-73. search Program-3 Investigators. Inflam-
11. Reddel HK, Bateman ED, Becker A, et matory and comorbid features of pa-
al. A summary of the new GINA strat- tients with severe asthma and frequent
egy: a roadmap to asthma control. Eur exacerbations. Am J Respir Crit Care
Respir J. 2015 Sep;46(3):622-39. Med. 2017 Feb 1;195(3):302-13.
12. Pavord I, Bahmer T, Braido F, et al. Se-
vere T2-high asthma in the biologicals 19. Reddel HK, Taylor DR, Bateman ED,
era: European experts’ opinion. Eur et al. An official American Thoracic
Respir Rev. 2019 Jul 8;28(152):190054. Society/European Respiratory Socie-
doi: 10.1183/16000617.0054-2019. ty statement: asthma control and exac-
13. Eger KAB, Amelink M, Hekking erbations: standardizing endpoints for
PP, et al. Overuse of oral corticos- clinical asthma trials and clinical prac-
teroids in asthma – modifiable fac- tice. Am J Respir Crit Care Med. 2009
tors and potential role of biologics. Jul 1;180(1):59-99.
Eur Respir J. 2019;54:OA5334; doi:
10.1183/13993003.congress-2019. 20. Loymans RJ, Sterk PJ. Exacerba-
OA5334. tor-prone asthma: a separate bioclini-
14. Suehs CM, Menzies-Gow A, Price cal phenotype? Am J Respir Crit Care
D, et al. Expert Consensus on the Ta- Med. 2017 Feb 1;195(3):275-7.
pering of Oral Corticosteroids for the
Treatment of Asthma. A Delphi Study. 21. Moore WC, Meyers DA, Wenzel SE,
Am J Respir Crit Care Med. 2021 Apr et al. Identification of asthma pheno-
1;203(7):871-81. types using cluster analysis in the Se-
15. To T, Stanojevic S, Moores G, et al. vere Asthma Research Program. Am
Global asthma prevalence in adults: J Respir Crit Care Med. 2010 Feb
finding from the cross-sectional world 15;181(4):315-23.
health survey. BMC Public Heath. 2012
Mar 19;12:204. doi: 10.1186/1471- 22. Federico MJ, Denlinger LC, Corren J,
2458-12-204. et al. Exacerbation-Prone Asthma: A
16. Stipić-Marković A, Pevec B, Radu- Biological Phenotype or a Social Con-
lović-Pevec M, et al. Prevalence of struct. J Allergy Clinical Immunol
symptoms of asthma, allergic rhini- Pract. 2021 Jul; 9(7):2627-34.
tis, conjunctivitis and atopic eczema:
ISAAC(International Study of Asthma 23. Ramsahai JM, Wark PAB. Appropri-
and Allergies in Childhood. in a pop- ate use of oral corticosteroids for se-
ulation of schoolchildren in Zagreb. vere asthma. Med J Aust. 2018 Jul
Acta Med Croatica. 2003;57(4):281-5. 16;209(S2):S18-S21.
24. Woodruff PG, Modrek B, Choy DF, et
al. T-helper type 2-driven inflammation
defines major subphenotypes of asthma.
Am J Respir Crit Care Med. 2009 Sep
1;80(5):388-95.
